TMAO and diabetes: from the gut feeling to the heart of the problem
Abstract Elevated plasma levels of trimethylamine N-oxide (TMAO)—a compound derived from diet and the gut microbiome—have been widely studied for their association with diabetes risk and their potential role in disease pathophysiology and complications. However, clinical studies, both prospective an...
Saved in:
| Main Authors: | Kinga Jaworska, Monika Kuś, Marcin Ufnal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Nutrition & Diabetes |
| Online Access: | https://doi.org/10.1038/s41387-025-00377-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
by: Si Hyoung Kim, et al.
Published: (2025-12-01) -
Probiotic Bifidobacterium reduces serum TMAO in unstable angina patients via the gut to liver to heart axis
by: Zhihong Zhou, et al.
Published: (2025-03-01) -
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons
by: Liu J, et al.
Published: (2025-04-01) -
Plasma TMAO Concentrations and Gut Microbiota Composition in Subjects with and Without Metabolic Syndrome: Results from Pilot Study
by: Mohammed E. Hefni, et al.
Published: (2025-05-01) -
Tanshinone regulated gut microbiota and TMAO to improve high-fat diet induced atherosclerosis in APOE−/− mice
by: Aiming Zhou, et al.
Published: (2025-07-01)